Literature DB >> 29626521

Wnt/β-catenin modulates chronic tobacco smoke exposure-induced acquisition of pulmonary cancer stem cell properties and diallyl trisulfide intervention.

Jiaye Wang1, Jiaqi Chen2, Ye Jiang3, Yingying Shi1, Jianyun Zhu4, Chunfeng Xie2, Shanshan Geng2, Jieshu Wu2, Qi Zhang2, Xiaoqian Wang2, Yu Meng2, Yuan Li2, Yue Chen2, Wanshuang Cao2, Xueqi Wang2, Caiyun Zhong5, Xiaoting Li6.   

Abstract

Lung cancer is the leading cause of cancer-related death worldwide; tobacco smoke (TS) constitutes the main causes of lung cancer. Acquisition of cancer stem cells (CSCs)-like properties is the essential progression for the initiation of lung cancer. However, the mechanisms for tobacco smoke-induced lung carcinogenesis remain elusive. In the present study, we demonstrated that long-term exposure of human bronchial epithelial (HBE) cells to TS resulted in malignant transformation and acquisition of CSC-like properties. Moreover, Wnt/β-catenin pathway was involved in acquisition of the CSC-like phenotype during neoplastic transformation of HBE cells induced by TS. Downregulation of β-catenin reduced the tumorsphere and decreased the protein expression of lung CSCs markers in TS-transformated HBE sphere-forming cells. Furthermore, Diallyl trisulfide (DATS) inhibited the CSCs activity of TS-transformed HBE cells, as well as Wnt/β-catenin suppression. Activation of Wnt/β-catenin diminished the inhibitory effects of DATS on TS-induced stemness of HBE cells. Together, the present investigation elucidates the modulation of Wnt/β-catenin in chronic TS exposure-triggered pulmonary acquisition of CSCs properties and DATS intervention, which may provide new insights into the interventional strategies against lung CSCs.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; DATS; Tobacco smoke; Wnt/β-catenin

Mesh:

Substances:

Year:  2018        PMID: 29626521     DOI: 10.1016/j.toxlet.2018.04.003

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  7 in total

Review 1.  Perspectives on Wnt Signal Pathway in the Pathogenesis and Therapeutics of Chronic Obstructive Pulmonary Disease.

Authors:  Jiao Qu; Li Yue; Jian Gao; Hongwei Yao
Journal:  J Pharmacol Exp Ther       Date:  2019-04-05       Impact factor: 4.030

Review 2.  Environmental exposures, stem cells, and cancer.

Authors:  Tasha Thong; Chanese A Forté; Evan M Hill; Justin A Colacino
Journal:  Pharmacol Ther       Date:  2019-07-31       Impact factor: 12.310

3.  Interleukin-17A mediates tobacco smoke-induced lung cancer epithelial-mesenchymal transition through transcriptional regulation of ΔNp63α on miR-19.

Authors:  Chunfeng Xie; Jianyun Zhu; Cong Huang; Xue Yang; Xiaoqian Wang; Yu Meng; Shanshan Geng; Jieshu Wu; Hongbin Shen; Zhibin Hu; Zili Meng; Xiaoting Li; Caiyun Zhong
Journal:  Cell Biol Toxicol       Date:  2021-04-03       Impact factor: 6.691

4.  Expression Level of Wnt5a Was Related to the Therapeutic Effects of First-Generation EGFR-TKIs.

Authors:  Hai Zhang; Xiaohua Yang; Fang Hu; Changhui Li; Jianlin Xu; Wei Nie; Yinchen Shen; Yuqing Lou; Baohui Han; Hua Zhong; Xueyan Zhang
Journal:  Onco Targets Ther       Date:  2020-06-11       Impact factor: 4.147

5.  Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33/p38 pathway.

Authors:  Chunfeng Xie; Jianyun Zhu; Xueqi Wang; Jiaqi Chen; Shanshan Geng; Jieshu Wu; Caiyun Zhong; Xiaoting Li
Journal:  J Exp Clin Cancer Res       Date:  2019-01-28

6.  Sulforaphane Inhibits the Acquisition of Tobacco Smoke-Induced Lung Cancer Stem Cell-Like Properties via the IL-6/ΔNp63α/Notch Axis.

Authors:  Chunfeng Xie; Jianyun Zhu; Ye Jiang; Jiaqi Chen; Xueqi Wang; Shanshan Geng; Jieshu Wu; Caiyun Zhong; Xiaoting Li; Zili Meng
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

Review 7.  Antioxidant Systems, lncRNAs, and Tunneling Nanotubes in Cell Death Rescue from Cigarette Smoke Exposure.

Authors:  Jose Lorenzo M Ferrer; Reynaldo L Garcia
Journal:  Cells       Date:  2022-07-23       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.